EcoDrugPlus

Tek Receptor Tyrosine Kinase

Ensembl ID : ENSSVLG00005023870
Gene Symbol: TEK
1 Cross references
164 Possible Orthologues:

Ttk Protein Kinase

Ensembl ID : ENSSVLG00005006338
Gene Symbol: TTK
1 Cross references
203 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSSVLG00005018173
Gene Symbol: UGCG
1 Cross references
211 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSSVLG00005016128
Gene Symbol: WEE1
1 Cross references
226 Possible Orthologues:

Acetylcholinesterase (Cartwright Blood Group)

Ensembl ID : ENSSVLG00005017422
Gene Symbol: ACHE
1 Cross references
233 Possible Orthologues:

Activin A Receptor Like Type 1

Ensembl ID : ENSSVLG00005017128
Gene Symbol: ACVRL1
1 Cross references
353 Possible Orthologues:

Activin A Receptor Type 2b

Ensembl ID : ENSSVLG00005024714
Gene Symbol: ACVR2B
1 Cross references
257 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSSVLG00005005154
Gene Symbol: ADORA2A
1 Cross references
260 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSSVLG00005010320
Gene Symbol: ADORA2B
1 Cross references
200 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSSVLG00005000518
Gene Symbol: ADA
1 Cross references
216 Possible Orthologues:

Adrenoceptor Alpha 1a

Ensembl ID : ENSSVLG00005002931
Gene Symbol: ADRA1A
1 Cross references
201 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSSVLG00005021005
Gene Symbol: ADRA1B
1 Cross references
263 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).